TCR-engineered T Cells in Solid Tumors (ACTengine IMA201-101)
NCT03247309
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
7
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumor
Cancer
Recurrent Solid Tumors
Refractory Solid Tumors
Interventions
BIOLOGICAL:
IMA201 Product
DIAGNOSTIC_TEST:
IMADetect®
Sponsor
Immatics US, Inc.